GlassScriptPhysician profile
Jacob J Bingham
NPI 1144609314
$48,929.97
in general payments reported to CMS, 2019-2025
14 companies · $3,168 in 2025
The $3,168 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29K · 2021: $16K · 2022: $13.30 · 2023: $262 · 2024: $1,027 · 2025: $3,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,776 · Food and Beverage: $1,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,775.59 |
| Food and Beverage | $1,680.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $26,350.18 | 2020-2025 | |
| Smith+Nephew, INC. | $17,710.96 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Stravix Mesh |
| Steelhead Surgical INC | $2,004.03 | 2021-2024 | |
| Wildwood Medical LLC | $1,336.85 | 2025 | |
| Stryker Corporation | $705.54 | 2021-2025 | T2, Variax, Axsos |
| Medical Device Business Services, INC. | $349.99 | 2021 | |
| Miach Orthopaedics, INC. | $170.57 | 2025 | |
| Shoulder Innovations, INC. | $90.86 | 2025 | Inset System |
| Skeletal Dynamics INC | $75.57 | 2024-2025 | Implate, Align, Ijs |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Vericel Corporation | $19.90 | 2021 | |
| Organogenesis INC. | $17.08 | 2023 | Puraply |
| Boston Scientific Corporation | $16.45 | 2023 | |
| Kci USA, INC. | $16.25 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.